159 related articles for article (PubMed ID: 8426488)
1. Myelodysplastic syndrome evolving into a myeloproliferative disorder: one disease or two?
Ohyashiki K; Yokoyama K; Kimura Y; Ohyashiki JH; Ito T; Kuratsuji T; Komatsumoto S; Nara M; Toyama K
Leukemia; 1993 Feb; 7(2):338-40. PubMed ID: 8426488
[TBL] [Abstract][Full Text] [Related]
2. Classification of the myelodysplastic syndromes.
Bennett JM
Clin Haematol; 1986 Nov; 15(4):909-23. PubMed ID: 3471370
[No Abstract] [Full Text] [Related]
3. A specific cutaneous lesion revealing myelodysplastic syndrome.
Kajisawa C; Matsui C; Morohashi M
Eur J Dermatol; 1998; 8(7):517-8. PubMed ID: 9854168
[TBL] [Abstract][Full Text] [Related]
4. Refractory cytopenia with multilineage dysplasia: further characterization of an 'unclassifiable' myelodysplastic syndrome.
Rosati S; Mick R; Xu F; Stonys E; Le Beau MM; Larson R; Vardiman JW
Leukemia; 1996 Jan; 10(1):20-6. PubMed ID: 8558932
[TBL] [Abstract][Full Text] [Related]
5. Recombinant human erythropoietin (rHuEPO) for treatment of myelodysplastic syndrome.
Zeigler ZR; Jones D; Rosenfeld CS; Shadduck RK
Stem Cells; 1993 Jan; 11(1):49-55. PubMed ID: 8457781
[TBL] [Abstract][Full Text] [Related]
6. Refractory anaemia with ringed sideroblasts associated with marked thrombocytosis (RARS-T) with superimposed 5q-syndrome.
Ziarkiewicz M; Dwilewicz-Trojaczek J; Pastwińska A; Chmarzyńska E; Paszkowska-Kowalewska M; Koperski Ł; Jędrzejczak WW; Ziarkiewicz-Wróblewska B
Pol J Pathol; 2010; 61(2):105-9. PubMed ID: 20924996
[TBL] [Abstract][Full Text] [Related]
7. Cyclosporin A in myelodysplastic syndrome: a preliminary report.
Dixit A; Chatterjee T; Mishra P; Choudhary DR; Mahapatra M; Saxena R; Choudhry VP
Ann Hematol; 2005 Sep; 84(9):565-8. PubMed ID: 15809884
[TBL] [Abstract][Full Text] [Related]
8. Leukocyte alkaline phosphatase score correlation with bone marrow blast percentage in myelodysplastic syndrome.
Lipshitz J; Limaye S; Patel D
Acta Haematol; 2010; 124(3):179-81. PubMed ID: 20962518
[No Abstract] [Full Text] [Related]
9. [The beneficial effect of 1,25-dihydroxycholecalciferol on the excess of blasts and the myelofibrosis in 2 cases of chronic myeloproliferative syndrome].
Raya Sánchez JM; Hernández Nieto L; Brito Barroso ML; Hernández García MT
Med Clin (Barc); 1994 Mar; 102(10):380-2. PubMed ID: 8182985
[TBL] [Abstract][Full Text] [Related]
10. In vitro culture techniques defining biological abnormalities in the myelodysplastic syndromes and myeloproliferative disorders.
Greenberg PL
Clin Haematol; 1986 Nov; 15(4):973-93. PubMed ID: 3552351
[No Abstract] [Full Text] [Related]
11. Diagnosing myelodysplastic/myeloproliferative neoplasms: laboratory testing strategies to exclude other disorders.
Hall J; Foucar K
Int J Lab Hematol; 2010 Dec; 32(6 Pt 2):559-71. PubMed ID: 20670271
[TBL] [Abstract][Full Text] [Related]
12. Refractory anemia in the elderly.
Gardner FH
Adv Intern Med; 1987; 32():155-75. PubMed ID: 3548248
[TBL] [Abstract][Full Text] [Related]
13. Harnessing the PD-1 Pathway in Myelodysplastic Syndrome.
Mukherjee S; Ibrahimi S; Aljumaily R; Cherry M
Am J Ther; 2018; 25(6):e711-e712. PubMed ID: 29394170
[No Abstract] [Full Text] [Related]
14. Chronic radiation-induced alteration in hematopoietic repair during preclinical phases of aplastic anemia and myeloproliferative disease: assessing unscheduled DNA synthesis responses.
Seed TM; Meyers SM
Cancer Res; 1993 Oct; 53(19):4518-27. PubMed ID: 8402623
[TBL] [Abstract][Full Text] [Related]
15. Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 17-1992. Repeated bouts of hematochezia in an 80-year-old hypertensive man.
N Engl J Med; 1992 Apr; 326(17):1137-46. PubMed ID: 1552915
[No Abstract] [Full Text] [Related]
16. [Isochromosome 17q as the sole alteration in 2 patients with a myelodysplastic syndrome and its relation to myeloperoxidase activity].
Solé F; Pérez A; Woessner S; Olmedo E; Florensa L; Sans J
Sangre (Barc); 1991 Aug; 36(4):323-5. PubMed ID: 1663663
[TBL] [Abstract][Full Text] [Related]
17. The myelodysplastic syndromes. Part I. What are they? Part II. Classification.
Galton DA
Scand J Haematol Suppl; 1986; 45():11-20. PubMed ID: 3515515
[No Abstract] [Full Text] [Related]
18. Low-dose melphalan for treatment of high-risk myelodysplastic syndromes.
Omoto E; Deguchi S; Takaba S; Kojima K; Yano T; Katayama Y; Sunami K; Takeuchi M; Kimura F; Harada M; Kimura I
Leukemia; 1996 Apr; 10(4):609-14. PubMed ID: 8618435
[TBL] [Abstract][Full Text] [Related]
19. Primary myelodysplastic syndrome: treatment of 6 patients with 13-cis retinoic acid.
Kerndrup G; Bendix-Hansen K; Pedersen B; Ellegaard J; Hokland P
Scand J Haematol Suppl; 1986; 45():128-32. PubMed ID: 3457443
[No Abstract] [Full Text] [Related]
20. Role of splenectomy in the treatment of myelodysplastic syndromes with peripheral thrombocytopenia: a report on six cases.
Bourgeois E; Caulier MT; Rose C; Dupriez B; Bauters F; Fenaux P
Leukemia; 2001 Jun; 15(6):950-3. PubMed ID: 11417482
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
